Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.

@article{Koopmans2008ImprovedSO,
  title={Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.},
  author={Klaas Pieter Koopmans and Oliver C. Neels and Ido P. Kema and Philip H. Elsinga and Wim J. Sluiter and Koen Vanghillewe and Adrienne H Brouwers and Pieter L. Jager and Elisabeth G. E. de Vries},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2008},
  volume={26 9},
  pages={1489-95}
}
PURPOSE To evaluate and compare diagnostic sensitivity of positron emission tomography (PET) scanning in carcinoid and islet cell tumor patients with a serotonin and a catecholamine precursor as tracers. PATIENTS AND METHODS Carcinoid (n = 24) or pancreatic islet cell tumor (n = 23) patients with at least one lesion on conventional imaging including somatostatin receptor scintigraphy (SRS) and computed tomography (CT) scan underwent (11)C-5-hydroxytryptophan ((11)C-5-HTP) PET and 6-[F-18… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 85 extracted citations

18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

European Journal of Nuclear Medicine and Molecular Imaging • 2013
View 8 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…